Replies to post #3158 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

The answer depends on the time horizon, which you didn't specify.

[DewDiligence]

Re: Buyout vig

PFE’s CEO said on today’s JPM webcast that he expects PFE to pursue more acquisitions like the BHVN (#msg-168806558) and ARNA (#msg-167101973) deals—i.e. companies with one major commercial product and modest R&D expenditures, enabling the acquisition to quickly—or immediately—be accretive to PFE’s EPS.

RVNC fits the above description.